1-4 of 4
David Lewis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Clinical Trials & Observations
Ann Tivey, Rohan Shotton, Toby A. Eyre, David Lewis, Louise Stanton, Rebecca Allchin, Harriet Walter, Fiona Miall, Rui Zhao, Anna Santarsieri, Rory McCulloch, Mark Bishton, Amy Beech, Victoria Willimott, Nicole Fowler, Claudia Bedford, Jack Goddard, Sam Protheroe, Angharad Everden, David Tucker, Josh Wright, Vasavi Dukka, Miriam Reeve, Shankara Paneesha, Mahesh Prahladan, Andrew Hodson, Iman Qureshi, Manasvi Koppana, Mary Owen, Kushani Ediriwickrema, Helen Marr, Jamie Wilson, Jonathan Lambert, David Wrench, Claire Burney, Chloe Knott, Georgina Talbot, Adam Gibb, Angela Lord, Barry Jackson, Simon Stern, Taylor Sutton, Amy Webb, Marketa Wilson, Nicky Thomas, Jane Norman, Elizabeth Davies, Lisa Lowry, Jamie Maddox, Neil Phillips, Nicola Crosbie, Marcin Flont, Emma Nga, Andres Virchis, Raisa Guerrero Camacho, Wunna Swe, Arvind Pillai, Clare Rees, James Bailey, Steve Jones, Susan Smith, Faye Sharpley, Catherine Hildyard, Sajir Mohamedbhai, Toby Nicholson, Simon Moule, Anshuman Chaturvedi, Kim Linton
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1209–1219.
https://doi.org/10.1182/bloodadvances.2023011152
Published: 2024
Includes: Supplemental data
Journal Articles

Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

Diego Villa, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J. Buege, Anita Kumar, David A. Bond, Jonas Paludo, Matthew J. Maurer, Gita Thanarajasingam, Katharine L. Lewis, Chan Y. Cheah, Joachim Baech, Tarec C. El-Galaly, Laveniya Kugathasan, David W. Scott, Alina S. Gerrie, David Lewis
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4576–4585.
https://doi.org/10.1182/bloodadvances.2023009804
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial

Clinical Trials & Observations
Christopher P. Fox, Ayesha S. Ali, Graham McIlroy, Steffi Thust, Nicolás Martinez-Calle, Aimee E. Jackson, Louise M. Hopkins, Catherine M. Thomas, Shireen Kassam, Josh Wright, Sridhar Chaganti, Jeffery Smith, Ian Chau, Dominic Culligan, Kim M. Linton, Graham P. Collins, Andrés J. M. Ferreri, David Lewis, Andrew J. Davies, Rod Johnson, Dorothee P. Auer, Kate Cwynarski
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4073–4082.
https://doi.org/10.1182/bloodadvances.2021004779
Published: 2021
Includes: Supplemental data
Journal Articles

Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial

Clinical Trials & Observations
Alex F. Herrera, Catherine Burton, John Radford, Fiona Miall, William Townsend, Armando Santoro, Pier Luigi Zinzani, David Lewis, Camilla Fowst, Satjit Brar, Bo Huang, Aron Thall, Graham P. Collins
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3387–3396.
https://doi.org/10.1182/bloodadvances.2021004511
Published: 2021
Includes: Supplemental data